Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2010 | 08-2010 | 05-2010 | 02-2010 | 11-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,585 | 2,403 | N/A | 5,835 | 3,718 |
| Depreciation Amortization | 2,602 | 1,306 | N/A | 2,391 | 1,541 |
| Income taxes - deferred | 737 | 375 | N/A | 1,818 | 474 |
| Accounts receivable | -5,765 | -887 | N/A | 1,245 | -1,145 |
| Accounts payable and accrued liabilities | 4,347 | 3,551 | N/A | -1,368 | 3,080 |
| Other Working Capital | -5,233 | 597 | N/A | -2,164 | -905 |
| Other Operating Activity | 795 | -2,962 | 0 | -677 | -2,555 |
| Operating Cash Flow | $2,068 | $4,383 | $N/A | $7,080 | $4,208 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,172 | -20,467 | N/A | -40,690 | -43,261 |
| PPE Investments | -3,450 | -1,676 | N/A | -3,745 | -3,159 |
| Investing Cash Flow | $-22,622 | $-22,143 | $N/A | $-44,435 | $-46,420 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,940 | -615 | N/A | N/A | N/A |
| Common Stock Issued | 109 | N/A | N/A | 17 | 17 |
| Common Stock Repurchased | -1,184 | -362 | N/A | N/A | N/A |
| Other Financing Activity | 1,199 | 818 | 0 | 218 | 958 |
| Financing Cash Flow | $-1,816 | $-159 | $N/A | $235 | $975 |
| Beginning Cash Position | 27,817 | 27,817 | N/A | 43,459 | 43,459 |
| End Cash Position | 5,447 | 9,898 | N/A | 6,339 | 2,222 |
| Net Cash Flow | $-22,370 | $-17,919 | $N/A | $-37,120 | $-41,237 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,068 | 4,383 | N/A | 7,080 | 4,208 |
| Capital Expenditure | -3,450 | -1,676 | N/A | -3,745 | -3,159 |
| Free Cash Flow | -1,382 | 2,707 | 0 | 3,335 | 1,049 |